IP Library Granted Patent US 12693343
Granted Patent B2
US 12693343 · App. 18/423,536 · Granted Jul 28, 2026

Method and control arrangement for mass scale production testing of secondary cells

Inventor: Sean Stephenson (Bureå, SE)
Assignee: Northvolt AB
G01R31/3865G01R31/3647G01R31/3648G01R31/367G01R31/392G01R31/01
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12693343
App. No.
18/423,536
Granted
Jul 28, 2026
Kind
B2
Abstract

The present disclosure pertains to testing of rechargeable cells for use in batteries arranged in electrical vehicles. According to a first aspect the disclosure relates to method for evaluating cell health of secondary cells 1 in mass scale production testing. The method comprises obtaining manufacturing data (i.e. data analysis 41 ) and generating scanning data by scanning 42 an inside of the secondary cells. The method further comprises determining cell quality using a prediction algorithm, performing additional testing 43 on a selection of the scanned secondary cells and verifying, based on the additional testing, accuracy of the prediction algorithm. The method thereafter comprises evaluating cell health of the individual cells 1 based on the cell quality determined using the prediction algorithm. The disclosure also relates to a corresponding control arrangement.

Claims (29)

1 . A method for evaluating cell health of secondary cells ( 1 ) in mass scale production testing, the method comprising:

obtaining (S 1 ) manufacturing data (d man ) recorded during cell manufacturing and associated with the secondary cells ( 1 ), and

upon the secondary cells ( 1 ) being fully assembled,

generating (S 2 ) scanning data (d scan ) by scanning an inside of, at least a subset of the secondary cells ( 1 ) using a radiation-based scanning technology,

determining (S 3 ) cell quality of the individual secondary cells using a prediction algorithm that predicts cell quality based on obtained manufacturing data (d prod ) and/or the generated scanning data (d scan ),

performing (S 4 ) additional testing using an alternative testing technology having higher reliability than the radiation-based scanning technology, only on a selection of the scanned secondary cells ( 1 ),

verifying (S 5 ), based on the additional testing, that accuracy of the prediction algorithm meets predefined accuracy requirements that must be met in order for the determined cell quality to form a basis for production testing, and

evaluating (S 7 ) cell health of the individual secondary cells ( 1 ) based on the cell quality determined using the prediction algorithm.

2 . The method of claim 1 , wherein the prediction algorithm comprises one or more of:

criteria applicable to identify, based on the scanning data, internal changes in secondary cells associated with cell degradation and/or different types of errors, and

criteria applicable to detect, based on the manufacturing data (d man ), potential manufacturing deviations associated with cell degradation and/or different types of errors.

3 . The method of claim 2 , wherein the obtained manufacturing data (d man ) comprises data collected during Formation and Ageing, F&A, slurry production and/or during electrode coating.

4 . The method of claim 1 , wherein the scanning is performed a predetermined time after cells ( 1 ) being fully formatted.

5 . The method of claim 1 , wherein the scanning is performed by a scanner ( 51 ) arranged at a production line.

6 . The method according to claim 5 , wherein cells ( 1 ) selected to undergo additional testing are side streamed on another line, different from the production line.

7 . The method of claim 1 , wherein the selection of secondary cells ( 1 ) selected for additional testing comprises:

high performing cells having scanning data (d scan ) exceeding an acceptance level for passing with a certain margin, and/or

outliers having scanning data (d scan ) within a risk interval just above the acceptance level for passing,

failing cells having scanning data (d scan ) failing to meet the acceptance level for passing with a certain margin, and

suspicious cells having deviating manufacturing data (d man ).

8 . The method of claim 1 , wherein the verifying (S 5 ) comprises comparing determined cell quality with cell quality determined based on the additional testing.

9 . The method of claim 1 , wherein the method further comprises:

updating (S 8 ) the prediction algorithm based on cell quality.

10 . The method of claim 1 , wherein the verifying (S 5 ) comprises investigating consequences of deviations in the obtained (S 1 ) manufacturing data.

11 . The method of claim 1 , wherein the radiation-based scanning technology comprises sound, such as ultrasound or echo sound.

12 . The method of claim 1 , further comprising:

developing (S 0 ) the prediction algorithm based on results from additional testing of secondary cells of different cell quality.

13 . The method of claim 1 , wherein the additional testing comprises one or more of; cell cycling, short circuit testing, over charging testing, nail penetration testing, thermal testing, or CT-scanning.

14 . A control arrangement ( 10 ) configured to perform the method according to claim 1 .